4//SEC Filing
Krasner Alan Seth 4
Accession 0001209191-22-015129
CIK 0001658247other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 9:00 PM ET
Size
7.3 KB
Accession
0001209191-22-015129
Insider Transaction Report
Form 4
Krasner Alan Seth
Chief Medical Officer
Transactions
- Award
Common Stock (right to buy)
2022-02-28+66,500→ 66,500 totalExercise: $20.02Exp: 2032-02-27→ Common Stock (66,500 underlying) - Award
Common Stock
2022-02-28+14,250→ 22,561 total
Footnotes (2)
- [F1]The transaction reported on this line involves the receipt of restricted stock units, which represent the right to receive shares of the Issuer's Common Stock, with 25% vesting annually beginning on March 15, 2023.
- [F2]The stock option shall vest and become exercisable in a series of forty-eight (48) successive equal monthly installments measured from the vesting commencement date of February 28, 2022.
Documents
Issuer
Crinetics Pharmaceuticals, Inc.
CIK 0001658247
Entity typeother
Related Parties
1- filerCIK 0001435775
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 9:00 PM ET
- Size
- 7.3 KB